American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
Open accessThe DOI matches its Crossref record; 648 of the 651 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AACE followed a rigorous developmental process based on strict methodology to systematically collect, objectively evaluate, and clearly summarize available scientific literature to develop trustworthy recommendations for clinical practice regarding care of persons with DM.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Research works printed but not linked: 6
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria, 1999, The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe, Lancet, 354, 617
- Disease, 2012, KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int Suppl, 2, 279
- Cheer, 2009, Managing complica- tions of the diabetic foot. BMJ., 339, b4905
- 1996, Neurology, 46, 873
- Heron, 2009, Deaths: final data for 2006, Natl Vital Stat Rep., 57, 1
- 2010, Insulin Infusion Pumps Panel Information.
Cited by
Items 101–200 of 558
A1C targets should be personalized to maximize benefits while limiting risks
Riddle, M. C., Gerstein, H. C., Holman, R. R., Inzucchi, S. E., Zinman, B., Zoungas, S., & Cefalu, W. T. (2018) · Diabetes Care · doi:10.2337/dci18-0018 · Cited by 54
Han, J., Tuan, N. Q., Park, M., Quan, K. T., Oh, J., Heo, K., Na, M., & Myung, C. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700769 · Cited by 53
Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes
Petri, K. C. C., Ingwersen, S. H., Flint, A., Zacho, J., & Overgaard, R. V. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13358 · Cited by 53
Bergman, M., Jagannathan, R., Buysschaert, M., Pareek, M., Olsen, M. H., Nilsson, P. M., Medina, J. L., Roth, J., Chetrit, A., Groop, L., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2992 · Cited by 56
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 73
Dardi, I., Kouvatsos, T., & Jabbour, S. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.005 · Cited by 61
LaManna, J., Litchman, M. L., Dickinson, J. K., Todd, A., Julius, M. M., Whitehouse, C. R., Hyer, S., & Kavookjian, J. (2019) · The Diabetes Educator · doi:10.1177/0145721719855931 · Cited by 50
Gestational diabetes mellitus: Multi-disciplinary treatment approaches
Kintiraki, E., & Goulis, D. G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.025 · Cited by 56
Grunberger, G., Handelsman, Y., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Haas, R. A., Roberts, V. L., & Umpierrez, G. E. (2018) · Endocrine Practice · doi:10.4158/ps-2017-0155 · Cited by 51
Self-citationBechini, A., Ninci, A., Riccio, M. D., Biondi, I., Bianchi, J., Bonanni, P., Mannucci, E., & Monami, M. (2020) · Vaccines · doi:10.3390/vaccines8020263 · Cited by 48
Update on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 58
Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes
Perreault, L., Rodbard, H. W., Valentine, V., & Johnson, E. L. (2019) · Advances in Therapy · doi:10.1007/s12325-018-0868-9 · Cited by 49
Divan, V., Greenfield, M., Morley, C. P., & Weinstock, R. S. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820978769 · Cited by 53
McAdam-Marx, C., White, K. N., & Gurgle, H. E. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s83088 · Cited by 48
Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2
Gupta, R., Lodha, S., Sharma, K. K., Sharma, S. K., Gupta, S., Asirvatham, A. J., Mahanta, B. N., Maheshwari, A., Sharma, D. C., Meenawat, A. S., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000275 · Cited by 48
Tajfard, M., Sany, S. B. T., Avan, A., Latiff, L. A., Rahimi, H. R., Moohebati, M., Hasanzadeh, M., Ghazizadeh, H., Esmaeily, H., Doosti, H., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27945 · Cited by 52
Health State Utilities Associated with Glucose Monitoring Devices
Matza, L. S., Stewart, K. D., Davies, E. W., Hellmund, R., Polonsky, W. H., & Kerr, D. (2017) · Value in Health · doi:10.1016/j.jval.2016.10.007 · Cited by 44
Witkowski, M., Wilkinson, L., Webb, N., Weids, A., Glah, D., & Vrazic, H. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0424-2 · Cited by 45
Atkinson, F. S., Villar, A., Mulà, A., Zangara, A., Risco, E., Smidt, C. R., Hontecillas, R., Leber, A. J., & Bassaganya-Riera, J. (2019) · Nutrients · doi:10.3390/nu11081757 · Cited by 48
Iqbal, M. Z., Khan, A. H., Iqbal, M., & Sulaiman, S. A. S. (2019) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_138_19 · Cited by 52
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 57
Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819894974 · Cited by 43
Chester, B., Stanely, W. G., & Geetha, T. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s178556 · Cited by 46
Owens, D. R., Traylor, L., Mullins, P. R., & Landgraf, W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.022 · Cited by 48
Matsuda, M., Bonatti, R., Marquezini, M. V., Garcia, M. L. B., Santos, U. D. P., Braga, A. L. F., Alves, M. R., Saldiva, P. H. N., & Monteiro, M. L. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143131 · Cited by 43
Sinclair, A. J., Dunning, T. L., Dhatariya, K., & an International Group of Experts (2019) · Diabetic Medicine · doi:10.1111/dme.14135 · Cited by 44
Healthcare resource utilization and cost among patients with type 1 diabetes in the United States
Simeone, J. C., Shah, S., Ganz, M. L., Sullivan, S., Koralova, A., LeGrand, J., & Bushman, J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.11.1399 · Cited by 41
Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease
Whayne, T. F., & Saha, S. P. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1086-z · Cited by 44
Chubb, B., Gupta, P., Gupta, J., Nuhoho, S., Kallenbach, K., & Orme, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01034-w · Cited by 39
Zhuo, M., D’Andrea, E., Paik, J. M., Wexler, D. J., Everett, B. M., Glynn, R. J., Kim, S. C., & Patorno, E. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.35995 · Cited by 43
Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE
Cornell, S. A. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.005 · Cited by 46
Alhadramy, M. S. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.02.001 · Cited by 54
Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia
Bailey, C. J. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12906 · Cited by 40
Yu, X., Xu, L., Zhou, Q., Wu, S., Tian, J., Piao, C., Guo, H., Zhang, J., Li, L., Wu, S., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/9519231 · Cited by 50
One‐year efficacy and safety of saxagliptin add‐on in patients receiving dapagliflozin and metformin
Matthaei, S., Aggarwal, N., García-Hernández, P. A., Iqbal, N., Chen, H., JOHNSSON, E. K., Chin, A., & Hansen, L. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12741 · Cited by 39
Rudy, M. D., Ahuja, N. K., & Aaronson, A. J. (2018) · JBJS Reviews · doi:10.2106/jbjs.rvw.17.00146 · Cited by 39
Hansen, B. B., Nuhoho, S., Ali, S. N., Dang-Tan, T., Valentine, W. J., Malkin, S. J. P., & Hunt, B. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1722678 · Cited by 36
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 44
Viswanathan, V., & Singh, K. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0052 · Cited by 47
Berkley‐Patton, J., Thompson, C. B., Bauer, A. G., Berman, M., Bradley‐Ewing, A., Goggin, K., Catley, D., & Allsworth, J. E. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00740-8 · Cited by 41
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness
Anderson, S. L., & Trujillo, J. M. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315609312 · Cited by 36
Sun, Y., Gao, Y., Ji, C. F., Sun, H., Cai, Y., Ge, L., Li, Y.-N., Zhang, J., & Tian, J. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153956 · Cited by 40
Mustafa, S. T., Hofer, O. J., Harding, J. E., Wall, C. R., & Crowther, C. A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab005 · Cited by 40
Chakkalakal, R. J., Galaviz, K. I., Thirunavukkarasu, S., Shah, M. K., & Narayan, K. M. V. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-060222-023417 · Cited by 35
Mechanick, J. I., Adams, S., Davidson, J. A., Fergus, I. V., Galindo, R. J., McKinney, K. H., Petak, S. M., Sadhu, A. R., Samson, S. L., Vedanthan, R., et al. (2019) · Endocrine Practice · doi:10.4158/ps-2019-0080 · Cited by 33
Self-citationHistory and future of omega-3 fatty acids in cardiovascular disease
Sperling, L. S., & Nelson, J. R. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1120190 · Cited by 34
Taylor, S. R., Meadowcraft, L., & Williamson, B. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1623 · Cited by 35
Roussel, R., Lorraine, J., Rodríguez, Á., & Salaun-Martin, C. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0261-x · Cited by 38
O’Brien, M. J., Lee, J. Y., Carnethon, M. R., Ackermann, R. T., Vargas, M. C., Hamilton, A., Mohanty, N., Rittner, S. S., Park, J. N., Hassan, A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002074 · Cited by 36
Anwer, M. A., Alfahed, O. B., Arif, S. I., Amer, Y. S., Titi, M. A., & Al-Rukban, M. O. (2017) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12785 · Cited by 35
Saxagliptin: A Review in Type 2 Diabetes
Dhillon, S. (2015) · Drugs · doi:10.1007/s40265-015-0473-z · Cited by 37
Simultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC–QToF-MS Method
Fachi, M. M., Cerqueira, L. B., Leonart, L. P., de Francisco, T. M. G., & Pontarolo, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167107 · Cited by 35
Blonde, L., Anderson, J. E., Chava, P., & Dendy, J. A. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1541790 · Cited by 33
Self-citationRias, Y. A., Kurniawan, A. L., Chang, C.-W., Gordon, C. J., & Tsai, H. (2020) · Antioxidants · doi:10.3390/antiox9100946 · Cited by 35
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT
Fuji, S., Rovó, A., Ohashi, K., Griffith, M., Einsele, H., Kapp, M., Mohty, M., Majhail, N. S., Engelhardt, B. G., Tichelli, A., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.81 · Cited by 35
Gautam, S., Agiro, A., Barron, J. O., Power, T. P., Weisman, H., & White, J. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0575-x · Cited by 35
Chen-Ku, C. H., González-Gálvez, G., Vásquez, M., Fuente, G. V., Nakazone, M. A., Giordano, A. I. S., & Pereira, M. H. D. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0473 · Cited by 33
Carbohydrate Intake Prior to Oral Glucose Tolerance Testing
Klein, K. R., Walker, C. P., McFerren, A. L., Huffman, H., Frohlich, F., & Buse, J. B. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab049 · Cited by 32
Fang, C., Peng, N., Cheng, J., Zhang, X., Gu, W., Zhu, Z., Yin, X., Yan, Z., Zhang, J., Yu, P., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02620-z · Cited by 36
Thyroid-Stimulating Hormone Levels Are Positively Associated with Insulin Resistance
Zhu, P., Liu, X., & Mao, X. (2018) · Medical Science Monitor · doi:10.12659/msm.905774 · Cited by 32
Predictors of type-2 diabetes remission following bariatric surgery after a two-year follow-up
Salman, M. A., Rabiee, A., Salman, A., Elewa, A., Tourky, M. S., Mahmoud, A. A., Moustafa, A., Shaaban, H. E., Ismail, A. A., Noureldin, K., et al. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.12.070 · Cited by 34
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
Lau, I. T., Lee, K. F., So, W. Y., Tan, K. C. B., & Yeung, M. W. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s131358 · Cited by 33
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians
Singh, A. K., Unnikrishnan, A., Zargar, A. H., Kumar, A., Das, A. K., Saboo, B., Sinha, B., Gangopadhyay, K. K., Talwalkar, P., Ghosal, S., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0562-1 · Cited by 39
Towards standardisation of evidence-based clinical care process specifications
McLachlan, S., Kyrimi, E., Dube, K., Hitman, G. A., Simmonds, J. A., & Fenton, N. (2020) · Health Informatics Journal · doi:10.1177/1460458220906069 · Cited by 37
Krzymień, J., & Ładyżyński, P. (2019) · Nutrients · doi:10.3390/nu11030607 · Cited by 42
West, D. S., Dutton, G. R., Delahanty, L. M., Hazuda, H. P., Rickman, A. D., Knowler, W. C., Vitolins, M. Z., Neiberg, R. H., Peters, A. L., Gee, M., et al. (2019) · Obesity · doi:10.1002/oby.22522 · Cited by 32
Patient Perceptions of Diabetes Guideline Frameworks for Individualizing Glycemic Targets
Schoenborn, N. L., Crossnohere, N. L., Bridges, J. F. P., Pollack, C. E., Pilla, S. J., & Boyd, C. M. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3806 · Cited by 31
Sultana, R., Sissoho, F., Kaushik, V. P., & Raji, M. A. (2022) · Life · doi:10.3390/life12081222 · Cited by 35
Liu, J., Bispham, J. A., Fan, L., Poon, J. L., Hughes, A. S., McAuliffe‐Fogarty, A. H., Varnado, O. J., & Mitchell, B. D. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038462 · Cited by 31
Mustad, V. A., Hegazi, R. A. F., Hustead, D. S., Budiman, E. S., Rueda, R., Maki, K. C., Powers, M. A., Mechanick, J. I., Bergenstal, R. M., & Hamdy, O. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001258 · Cited by 30
Self-citationGlurich, I., Nycz, G. R., & Acharya, A. (2017) · Clinical Medicine & Research · doi:10.3121/cmr.2017.1348 · Cited by 30
Comparative Effectiveness for Glycemic Control in Older Adults with Diabetes
Quartuccio, M., Buta, B. J., & Kalyani, R. R. (2017) · Current Geriatrics Reports · doi:10.1007/s13670-017-0215-z · Cited by 32
The Screening and Prevention of Diabetes Mellitus
Martinez, L. C., Sherling, D. H., & Holley, A. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.10.006 · Cited by 34
Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
Triplitt, C. L., & Cornell, S. A. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s31526 · Cited by 31
Ortiz, M. R. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.07.006 · Cited by 29
Orme, M., Nguyen, H., Lu, J., & Thomas, S. (2017) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s116810 · Cited by 27
Stone, J. Y., Haviland, N., & Bailey, T. S. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0099 · Cited by 28
Self-citationZhang, Z., Jiao, Z., Blaha, M. J., Osei, A. D., Sidhaye, V. K., Ramanathan, M., & Biswal, S. S. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.12.009 · Cited by 30
Gupta, S., Teede, H. J., & Aroni, R. (2017) · Appetite · doi:10.1016/j.appet.2017.10.007 · Cited by 30
Smith, E. D., Layden, B. T., Hassan, C., & Sánchez-Johnsen, L. (2017) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2017.0037 · Cited by 27
Diabetes, dysglycemia, and vascular surgery
Duwayri, Y. M., & Jordan, W. D. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.05.027 · Cited by 31
Shuhaida, M. H. N., Yusoff, S. S. M., Kadir, A. A., Norhayati, M. N., Draman, N., & Muhammad, J. (2019) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2019.03.002 · Cited by 30
Raj, G. M., Mathaiyan, J., Wyawahare, M., & Priyadarshini, R. (2018) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0030 · Cited by 26
Mechanick, J. I., Pessah-Pollack, R., Camacho, P., Correa, R., Figaro, M. K., Garber, J. R., Jasim, S., Pantalone, K. M., Trence, D., & Upala, S. (2017) · Endocrine Practice · doi:10.4158/ep171866.gl · Cited by 25
Self-citationLivingston, M. A., Downie, P., Hackett, G. I., Marrington, R., Heald, A. H., & Ramachandran, S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13607 · Cited by 25
Baldwin, D. S., Necking, O., Schmidt, S. N., Ren, H., & Reines, E. H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.098 · Cited by 28
Lajara, R., Davidson, J. A., NIKKEL, C. C., & Morris, T. L. (2016) · Endocrine Practice · doi:10.4158/ep151182.or · Cited by 25
Self-citationPrediabetes: Screening, Diagnosis, and Intervention
Watson, C. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.08.005 · Cited by 26
Vaughan, E. M., Johnston, C. A., Hyman, D. J., Hernandez, D. C., Hemmige, V. S., & Foreyt, J. P. (2017) · Journal of Primary Care & Community Health · doi:10.1177/2150131917745760 · Cited by 24
Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US
Shealy, K. M., Wu, J., Waites, J., Taylor, N. A., & Sarbacker, G. B. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.02.180259 · Cited by 24
Yasuno, T., Maeda, T., Tada, K., Takahashi, K., Ito, K., Abe, Y., Mukoubara, S., Masutani, K., Arima, H., & Nakashima, H. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3242-19 · Cited by 25
Salinero-Fort, M. Á., Andrés-Rebollo, F. J. S., Cárdenas‐Valladolid, J., Méndez‐Bailón, M., Chico-Moraleja, R. M., Pau, E. C. D. S., Jiménez‐Trujillo, I., Gómez-Campelo, I., de Burgos‐Lunar, C., de Miguel-Yanes, J. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94121-8 · Cited by 25
Lajara, R., Fetchick, D. A., Morris, T. L., & NIKKEL, C. C. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0138-7 · Cited by 24
Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives
John, M., Gopinath, D., & Jagesh, R. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.172268 · Cited by 25
Quansah, D. Y., Ha, K., Jun, S., Kim, S.-A., Shin, S., Wie, G.-A., & Joung, H. (2017) · Molecules · doi:10.3390/molecules22101664 · Cited by 25
Hinnen, D., & Strong, J. L. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0014 · Cited by 24
Gui, T., Lin, Y., Huan, S., Li, Y., Wang, B., Yang, J., Gu, R., Liu, Q., Li, Z., Li, S., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28592 · Cited by 24
Bain, S. C., Feher, M. D., Russell-Jones, D. L., & Khunti, K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12760 · Cited by 27
Magee, M. F., Nassar, C. M., Mete, M. Y., White, K., Youssef, G. A., & Dubin, J. S. (2015) · Endocrine Practice · doi:10.4158/ep15655.or · Cited by 23
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
Ikeda, M., & Shimazawa, R. (2019) · Journal of General and Family Medicine · doi:10.1002/jgf2.244 · Cited by 28
Metadata
- Authors
- Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O. P., Garber, A. J., Garvey, W. T., Henry, R. R., Hirsch, I. B., Horton, E. S., Hurley, D. L., Jellinger, P. S., Jovanovič, L., Lebovitz, H. E., LeRoith, D., Levy, P., McGill, J. B., Mechanick, J. I., Mestman, J. H., Moghissi, E. S., Orzeck, E. A., Pessah-Pollack, R., Rosenblit, P. D., Vinik, A. I., Wyne, K., & Zangeneh, F.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Wayne State University (US)
- Emory University (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Louisiana State University (US)
- University of Tennessee Health Science Center (US)
- American Association of Clinical Endocrinologists (US)
- Joslin Diabetes Center (US)
- Harvard University (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- Mayo Clinic (US)
- University of Southern California (US)
- State University of New York (US)
- University of Arizona (US)
- Washington University in St. Louis (US)
- University of California, Los Angeles (US)
- University of California, Irvine (US)
- Eastern Virginia Medical School (US)
- Houston Methodist (US)
- Corresponding author
- Zangeneh, Farhad
- ORCID
- Handelsman, Yehuda
- Bloomgarden, Zachary T.
- Grunberger, George
- Umpierrez, Guillermo
- Zimmerman, Robert S.
- Bailey, Timothy S.
- Blonde, Lawrence
- Bray, George A.
- Dagogo-Jack, Samuel
- Davidson, Jaime A.
- Einhorn, Daniel
- Ganda, Om P.
- Garvey, W. Timothy
- Henry, Robert R.
- Hirsch, Irl B.
- Horton, Edward S.
- Hurley, Daniel L.
- McGill, Janet B.
- Mechanick, Jeffrey I.
- Vinik, Aaron I.
- Wyne, Kathleen
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 21
- Pages
- 1-87
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W4240794548
- Cited by
- 559
- References
- 651
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 20 · 2023: 22 · 2022: 41 · 2021: 41 · 2020: 67 · 2019: 62 · 2018: 86 · 2017: 77 · 2016: 93 · 2015: 40
- FWCI
- 85.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- Funders
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Novartis
- Sanofi
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
- Asahi Kasei Pharma Corporation
- Zoetis
- Amarin Corporation
- Novo Nordisk
- St. Jude Medical
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, comprehensive care plan, diabetes management, clinical decision-making, patient-centered care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.